The Epidemiology of Myasthenia Gravis

 

 Buy Article Permissions and Reprints

Epidemiology is the study of a disease in a population. The epidemiology of myasthenia gravis (MG) has been studied for over 50 years, and over 50 studies have been published in one form or another. The published prevalence has steadily increased, and one can estimate that there are ∼60,000 patients with MG in the United States. The current trends indicate that, as the population ages, an increasing number of patients with MG can be expected, but the clinical patterns of the disease may change.

REFERENCES

• 1 Cambridge Dictionary of American English .Available at: http://dictionary.cambridge.org/define.asp?key=anecdote*1+0&dict+A. Accessed November 24 2003
• 2 Phillips L H. The epidemiology of myasthenia gravis.  Ann N Y Acad Sci. 2003;  998 407-412
  CrossrefPubMedSearch in Google Scholar
• 3 Phillips L H, Torner J C. Epidemiologic evidence for a changing natural history of myasthenia gravis.  Neurology. 1996;  47 1233-1238
  PubMedSearch in Google Scholar
• 4 Poulas K, Tsibri E, Kokla A et al.. Epidemiology of seropositive myasthenia gravis in Greece.  J Neurol Neurosurg Psychiatry. 2001;  71 352-356
  CrossrefPubMedSearch in Google Scholar
• 5 Kalb B, Matell G, Pirskanen R, Lambe M. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden.  Neuroepidemiology. 2002;  21 221-225
  CrossrefPubMedSearch in Google Scholar
• 6 Wirtz P W, Nijnuis M G, Sotodeh M et al.. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.  J Neurol. 2003;  250 698-701
  PubMedSearch in Google Scholar
• 7 Isbister C M, Mackenzie P J, Anderson D et al.. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia: a population-based study [abstract].  Neurology. 2002;  58(suppl 3) A185-A186
  PubMedSearch in Google Scholar
• 8 Phillips L H, Torner J C, Anderson M S et al.. The epidemiology of myasthenia gravis in central and western Virginia.  Neurology. 1992;  42 1888-1893
  CrossrefPubMedSearch in Google Scholar
• 9 Jaretzke A, Barohn R J, Ernstoff R M et al.. Myasthenia gravis. Recommendations for clinical research standards.  Neurology. 2000;  55 16-23
  PubMedSearch in Google Scholar
• 10 Vincent A, Clover L, Buckley C et al.. Evidence of underdiagnosis of myasthenia gravis in older people.  J Neurol Neurosurg Psychiatry. 2003;  74 1105-1108
  CrossrefPubMedSearch in Google Scholar
• 11 Nations S P, Wolfe G I, Amato A A et al.. Distal myasthenia gravis.  Neurology. 1999;  52 632-634
  PubMedSearch in Google Scholar
• 12 Uncini A, Di Guglielmo G, Di Muzio A et al.. Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy.  J Neurol Neurosurg Psychiatry. 1997;  63 414-415
  PubMedSearch in Google Scholar
• 13 Werner P, Kiechl S, Löscher S et al.. Distal myasthenia gravis: frequency and clinical course in a large prospective series.  Acta Neurol Scand. 2003;  108 209-210
  CrossrefPubMedSearch in Google Scholar
• 14 Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.  Nat Med. 2001;  7 365-368
  CrossrefPubMedSearch in Google Scholar
• 15 Sanders D B, El-Salem K, Massey J M, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG.  Neurology. 2003;  60 1978-1980
  CrossrefPubMedSearch in Google Scholar
• 16 Pascuzzi R M. Controlled clinical trials of anything in myasthenia gravis.  Arch Neurol. 1997;  54 1323
  PubMedSearch in Google Scholar
• 17 Tindall R SA, Rollins J A, Phillips J T et al.. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis.  N Engl J Med. 1987;  316 719-724
  CrossrefPubMedSearch in Google Scholar
• 18 Mantegazza R, Baggi F, Antozzi C et al.. Myasthenia gravis (MG): epidemiological data and prognostic factors.  Ann N Y Acad Sci. 2003;  998 413-423
  CrossrefPubMedSearch in Google Scholar
• 19 Paul R H, Nash J M, Cohen R A et al.. Quality of life and well-being of patients with myasthenia gravis.  Muscle Nerve. 2001;  24 512-516
  PubMedSearch in Google Scholar

Lawrence H Phillips IIM.D. 

Department of Neurology, University of Virginia, Box 800394, Charlottesville, VA 22908